199
Views
3
CrossRef citations to date
0
Altmetric
CASE REPORT

Lithium-Associated Generalized Ostraceous Psoriasis Treated with Adalimumab: A Case Report

ORCID Icon &
Pages 947-950 | Received 11 Feb 2023, Accepted 31 Mar 2023, Published online: 06 Apr 2023

References

  • Sérgio M. Psoríase ostrácea: relato de caso = Ostraceous psoriasis: case report. An Bras Dermatol. 2002;2002:207–210.
  • Estrada BD, Azevedo PM, Tamler C, et al. Dermatologia comparativa: psoríase hiperceratósica. Comparative dermatology: hyperkeratotic psoriasis. An Bras Dermatol. 2007;82(4):369–371. doi:10.1590/s0365-05962007000400013
  • Basavaraj KH, Ashok NM, Rashmi R, et al. The role of drugs in the induction and/or exacerbation of psoriasis. Int J Dermatol. 2010;49(12):1351–1361. doi:10.1111/j.1365-4632.2010.04570.x
  • Jafferany M. Lithium and skin: dermatologic manifestations of lithium therapy. Review. Int J Dermatol. 2008;47(11):1101–1111. doi:10.1111/j.1365-4632.2008.03873.x
  • Chiricozzi A, Zangrilli A, Bavetta M, et al. Real-life 9-year experience with Adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. J Eur Acad Dermatol Venereol. 2017;31(2):304–311. doi:10.1111/jdv.13771
  • Raychaudhuri SK, Maverakis E, Raychaudhuri SP. Diagnosis and classification of psoriasis. Autoimmun Rev. 2014;13(4–5):490–495. doi:10.1016/j.autrev.2014.01.008
  • Ip KH, Cheng HS, Oliver FG. Rupioid Psoriasis. JAMA Dermatol. 2021;157(7):859. doi:10.1001/jamadermatol.2021.0451
  • Arias-Santiago SA, Naranjo-Sintes R. Generalized ostraceous psoriasis. N Engl J Med. 2010;362(2):155. doi:10.1056/NEJMicm0810475
  • Situm M, Kolic M, Buljan M. PSYCHODERMATOLOGY.; Review. Acta Clin Croat. 2016;70(Suppl 1):35–38.
  • Rivera-Oyola R, Stanger R, Litchman GH, et al. The use of brodalumab in three patients with psoriasis and psychiatric comorbidities. J Clin Aesthet Dermatol. 2020;13(12):44–48.
  • Bernardini N, Skroza N, Prevete E, et al. Guselkumab for the treatment of severe plaque psoriasis in a schizophrenia patient. Dermatol Rep. 2022;14(4):9476. doi:10.4081/dr.2022.9476